Ventricular Assist Devices (VADs) Market in LAMEA is expected to register a CAGR of 12.9% during the forecast period (2018 – 2024) – KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report LAMEA Ventricular Assist Devices (VADs) Market, published by KBV research, the LAMEA Ventricular Assist Devices (VADs) Market would witness market growth of 12.9% CAGR during the forecast period (2018 – 2024).

The Brazil market would dominate the LAMEA Implantable Ventricular Assist Devices Market by Country 2024; growing at a CAGR of 11.6 % during the forecast period. The Argentina market is expected to witness a CAGR of 13.3% during (2018 - 2024). Additionally, the UAE market is expected to witness a CAGR of 12% during (2018 - 2024).

The Bridge-to-transplant (BTT) Therapy market dominated the LAMEA Ventricular Assist Devices Market by Application 2017, growing at a CAGR of 11.9 % during the forecast period. The Destination Therapy market is expected to witness a CAGR of 12.7% during (2018 - 2024). The Bridge-to-recovery (BTR) Therapy market is expected to witness a CAGR of 14.4% during (2018 - 2024). Additionally, the Bridge-to-candidacy (BTC) Therapy market is expected to witness highest CAGR of 15.2% during (2018 - 2024).

The Left Ventricular Assist Devices (LVADs) market dominated the Saudi Arabia Ventricular Assist Devices Market by Product 2017; thereby, achieving a market value of $17.7 million by 2024,. The Right Ventricular Assist Devices (RVADs) market is expected to witness a CAGR of 12.6% during (2018 - 2024). Additionally, the Biventricular Assist Devices (BIVADs) market is expected to witness highest CAGR of 12.2% during 2018 - 2024.

Full Report: https://www.kbvresearch.com/lamea-ventricular-assist-devices-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Berlin Heart GmbH, Cardiac Assist, Inc. ( LivaNova), HeartWare International, Inc., Jarvik Heart, Inc., Reliant Heart, Inc., Abbott, Sun Medical Technology Research Corp., Syncardia System, Inc., Thoratec Corporation and Abiomed

LAMEA Ventricular Assist Devices (VADs) Market Segmentation

By Product

  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)

By Design

  • Implantable Ventricular Assist Devices
  • Transcutaneous Ventricular Assist Devices

By Application

  • Bridge-to-transplant (BTT) Therapy
  • Destination Therapy
  • Bridge-to-recovery (BTR) Therapy
  • Bridge-to-candidacy (BTC) Therapy

 By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Berlin Heart GmbH,
  • Cardiac Assist, Inc. ( LivaNova)
  • HeartWare International, Inc.
  • Jarvik Heart, Inc.
  • Reliant Heart, Inc.
  • Abbott
  •  Sun Medical Technology Research Corp.
  • Syncardia System, Inc.
  • Thoratec Corporation
  • Abiomed

Unique Offerings from KBV Research

  • Exhaustive coverage  
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Ventricular Assist Devices Market

North America Ventricular Assist Devices Market

Europe Ventricular Assist Devices Market

Asia Pacific Ventricular Assist Devices Market

 

 

 

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.